Search Results - "MacEwan, Joanna P."

Brentuximab Vedotin Retreatment in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma or Peripheral T-Cell Lymphoma: A Retrospective United States Claims Analysis by Sano, Dahlia, Liu, Nicholas, Knowles, Scott, MacEwan, Joanna P, Wang, Shu, Wogen, Jenifer, Yu, Kristina S, Lee, Seung Tae

“…Brentuximab vedotin (BV) monotherapy (BV-M) and combination (BV-C) therapies are safe and effective for classical Hodgkin lymphoma (cHL) and CD30-expressing…”
Get full text

Clinical, economic, and health‐related quality of life outcomes in patients with overweight or obesity in the United States: 2016–2018 by MacEwan, Joanna P., Chiu, Kevin, Ahmad, Nadia N., Sacks, Naomi, Shinde, Shraddha, Poon, Jiat Ling, Kan, Hong

“…Objectives This study aimed to estimate clinical, economic (including productivity), and health‐related quality of life (HRQoL) outcomes and associated…”
Get full text

Diagnosis, testing, treatment, and outcomes among patients with advanced non‐small cell lung cancer in the United States by Yang, Mo, MacEwan, Joanna P., Boppudi, Sai Sriteja, McClain, Monica R., O'Hara, Richard M., Paik, Paul K.

“…Introduction Characteristics of patients in clinical trials may differ from those of real‐world patients. Our objective was to describe biomarker testing and…”
Get full text

The value of survival gains from therapeutic innovations for US patients with relapsed/refractory multiple myeloma by MacEwan, Joanna P, Majer, Istvan, Chou, Jacquelyn W, Panjabi, Sumeet

“…Aims: This study quantifies the value of survival gains attributable to novel treatments approved since 2003 for United States (US) patients with…”
Get full text

Physician and Patient Preferences for Nonvalvular Atrial Fibrillation Therapies by Shafrin, Jason, PhD, Bruno, Amanda, PhD, MacEwan, Joanna P., PhD, Campinha-Bacote, Avrita, MPH, Trocio, Jeffrey, MPH, Shah, Manan, PhD, Tan, Wilson, MD, MRCS, Romley, John A., PhD

“…Abstract Objectives The objective of this study was to compare patient and physician preferences for different antithrombotic therapies used to treat…”
Get full text

Estimating Productivity Loss from Breast and Non–Small-Cell Lung Cancer among Working-Age Patients and Unpaid Caregivers: A Survey Study Using the Multiplier Method by Chiu, Kevin, MacEwan, Joanna P., May, Suepattra G., Bognar, Katalin, Peneva, Desi, Zhao, Lauren M., Yong, Candice, Amin, Suvina, Bolinder, Bjorn, Batt, Katharine, Baumgardner, James R.

“…Background. Traditional approaches to capturing health-related productivity loss (e.g., the human capital method) focus only on the foregone wages of affected…”
Get full text

Non–Small Cell Lung Cancer Patient Preferences for First-Line Treatment: A Discrete Choice Experiment by MacEwan, Joanna P., Gupte-Singh, Komal, Zhao, Lauren M., Reckamp, Karen L.

“…Background. There has been much innovation in the treatment of non–small cell lung cancer (NSCLC) in recent years. In particular, use of immuno-oncology (IO)…”
Get full text

The Value of Progression-Free Survival in Metastatic Breast Cancer: Results From a Survey of Patients and Providers by MacEwan, Joanna P., Doctor, Jason, Mulligan, Karen, May, Suepattra G., Batt, Katharine, Zacker, Christopher, Lakdawalla, Darius, Goldman, Dana

“…Background. Value assessments and treatment decision making typically focus on clinical endpoints, especially overall survival (OS). However, OS data are not…”
Get full text

Outcomes of Warfarin Home INR Monitoring vs Office-Based Monitoring: a Retrospective Claims-Based Analysis by Van Beek, Andrea, Moeyaert, Mariola, Ragheb, Bishoy, Price, Erika, MacEwan, Joanna P., Ahmed, Naseeruddin, Ansell, Jack

“…Background Home INR testing (patient self-testing) is feasible and effective for warfarin patients but little is known about real-world differences in outcomes…”
Get full text

S126 Time to Initiation of the Second-Line Therapy Obeticholic Acid in Patients With Primary Biliary Cholangitis by Kumar, Sonal, MacEwan, Joanna P., Levine, Alina, Bessonova, Leona, Nair, Radhika, Wheeler, Darren, Li, Jing, Brown, Robert S.

Get full text

Cognition and education benefits of increased hemoglobin and blood oxygenation in children with sickle cell disease by MacEwan, Joanna P, King, Allison A, Nguyen, Andy, Mubayi, Anuj, Agodoa, Irene, Smith-Whitley, Kim

“…Among individuals with sickle cell disease (SCD), decreased hemoglobin is associated with lower oxygen saturation (SpO2) and increased risk of stroke, both of…”
Get full text

S124 Association of Elevated Liver Biochemistries and Clinical Outcomes Within Strata of Alkaline Phosphatase Levels in Patients With Primary Biliary Cholangitis by Victor, David W., MacEwan, Joanna P., Hernandez, Jennifer, Nair, Radhika, Kamal, Mustafa, Wheeler, Darren, Li, Jing, Bessonova, Leona, Gasink, Christopher, Kowdley, Kris V.

Get full text

Limitations of traditional health technology assessment methods and implications for the evaluation of novel therapies by Doctor, Jason, MacEwan, Joanna P.

Get full text

Changes in mortality associated with cancer drug approvals in the United States from 2000 to 2016 by MacEwan, Joanna P, Dennen, Syvart, Kee, Rebecca, Ali, Farzad, Shafrin, Jason, Batt, Katharine

“…To estimate the extent to which the approvals of new pharmacological therapies were associated with cancer mortality in the USA between 2000 and 2016. The…”
Get more information

Patterns of Adherence to Oral Atypical Antipsychotics Among Patients Diagnosed with Schizophrenia by MacEwan, Joanna P, Forma, Felicia M, Shafrin, Jason, Hatch, Ainslie, Lakdawalla, Darius N, Lindenmayer, Jean-Pierre

“…Poor medication adherence contributes to negative treatment response, symptom relapse, and hospitalizations in schizophrenia. Many health plans use…”
Get full text

Economic burden of multiple myeloma among patients in successive lines of therapy in the United States by MacEwan, Joanna P., Batt, Katharine, Yin, Wes, Peneva, Desi, Sison, Steve, Vine, Seanna, Chen, Clara

“…This study characterized the costs of multiple myeloma (MM) during first-line (1L), second-line (2L) and third-line (3L) treatment from the US payer…”
Get full text

Two steps forward, one step back: 50 years of societal value from LDL-C-lowering therapies by MacEwan, Joanna P, Zhao, Lauren M, Everson, Katie, Liu, Larry, Lautsch, Dominik, Sun, Fang, Lakdawalla, Darius N

“…To assess the evolving landscape of low-density lipoprotein cholesterol-lowering therapies (LLTs) and quantify their effect on cardiovascular disease…”
Get full text

A comparison of diagnosed and undiagnosed diabetes patients and labor supply by Minor, Travis, MacEwan, Joanna P.

“…•We examine the differences and similarities between diagnosed and undiagnosed cases of type 2 diabetes.•Diagnosed type 2 diabetes is associated with a…”
Get full text

Hospital Readmission Rates Among Patients With Schizophrenia Treated With Long-Acting Injectables or Oral Antipsychotics by MacEwan, Joanna P, Kamat, Siddhesh A, Duffy, Ruth A, Seabury, Seth, Chou, Jacquelyn W, Legacy, Susan N, Hartry, Ann, Eramo, Anna, Karson, Craig

“…Objective:This study analyzed hospital readmission rates of patients with schizophrenia who were treated with long-acting injectable antipsychotics (LAIs) or…”
Get full text

What do pharmaceuticals really cost in the long run? by Lakdawalla, Darius, MacEwan, Joanna P, Dubois, Robert, Westrich, Kimberly, Berdud, Mikel, Towse, Adrian

“…To estimate the long-run average cost (LAC) for a typical drug, accounting for the effects of generic competition and medical cost offsets. Descriptive…”
Get full text